icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research

Immunoinformatics Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2024

May 28, 2019

Summary adds “Immunoinformatics Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field’s main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations. 
In 2018, the global Immunoinformatics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immunoinformatics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunoinformatics development in United States, Europe and China.

The key players covered in this study 
Novozymes Biopharma 
International Society of Vaccines 
Dassault Systemes 
Chemical Computing Group 
Genedata AG 
Insilico Biotechnology AG 
Leadscope Inc 
Nimbus Discovery 
Strand Life Sciences 
Simulation Plus 
Rosa & Co

Request a Free Sample Report @

Market segment by Type, the product can be split into 
Cancer Diagnosis & Therapy 
Reverse Vaccinology 
Immune System Modeling

Market segment by Application, split into 
Allergy Prediction Databases 
Analysis Resource Database 
International Immunogenetics System 
The Ontology Of Immune Epitopes 
Immune Epitope Database

Market segment by Regions/Countries, this report covers 
United States 
Southeast Asia 
Central & South America

The study objectives of this report are: 
To analyze global Immunoinformatics status, future forecast, growth opportunity, key market and key players. 
To present the Immunoinformatics development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immunoinformatics are as follows: 
History Year: 2014-2018 
Base Year: 2018 
Estimated Year: 2019 
Forecast Year 2019 to 2025 
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Complete Report details @

Major Key Points in Table of Content

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Immunoinformatics Market Size Growth Rate by Type (2014-2025) 
1.4.2 Cancer Diagnosis & Therapy 
1.4.3 Reverse Vaccinology 
1.4.4 Immune System Modeling 
1.5 Market by Application 
1.5.1 Global Immunoinformatics Market Share by Application (2014-2025) 
1.5.2 Allergy Prediction Databases 
1.5.3 Analysis Resource Database 
1.5.4 International Immunogenetics System 
1.5.5 The Ontology Of Immune Epitopes 
1.5.6 Immune Epitope Database 
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 Immunoinformatics Market Size 
2.2 Immunoinformatics Growth Trends by Regions 
2.2.1 Immunoinformatics Market Size by Regions (2014-2025) 
2.2.2 Immunoinformatics Market Share by Regions (2014-2019) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities


12 International Players Profiles 
12.1 EpiVax 
12.1.1 EpiVax Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Immunoinformatics Introduction 
12.1.4 EpiVax Revenue in Immunoinformatics Business (2014-2019) 
12.1.5 EpiVax Recent Development 
12.2 Novozymes Biopharma 
12.2.1 Novozymes Biopharma Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Immunoinformatics Introduction 
12.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2014-2019) 
12.2.5 Novozymes Biopharma Recent Development 
12.3 ioGenetics 
12.3.1 ioGenetics Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Immunoinformatics Introduction 
12.3.4 ioGenetics Revenue in Immunoinformatics Business (2014-2019) 
12.3.5 ioGenetics Recent Development 
12.4 International Society of Vaccines 
12.4.1 International Society of Vaccines Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Immunoinformatics Introduction 
12.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2014-2019) 
12.4.5 International Society of Vaccines Recent Development 
12.5 IMGT 
12.5.1 IMGT Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Immunoinformatics Introduction 
12.5.4 IMGT Revenue in Immunoinformatics Business (2014-2019) 
12.5.5 IMGT Recent Development 
12.6 Dassault Systemes 
12.6.1 Dassault Systemes Company Details 
12.6.2 Company Description and Business Overview 
12.6.3 Immunoinformatics Introduction 
12.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2014-2019) 
12.6.5 Dassault Systemes Recent Development 
12.7 Certara 
12.7.1 Certara Company Details 
12.7.2 Company Description and Business Overview 
12.7.3 Immunoinformatics Introduction 
12.7.4 Certara Revenue in Immunoinformatics Business (2014-2019) 
12.7.5 Certara Recent Development 
12.8 Chemical Computing Group 
12.8.1 Chemical Computing Group Company Details 
12.8.2 Company Description and Business Overview 
12.8.3 Immunoinformatics Introduction 
12.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2014-2019) 
12.8.5 Chemical Computing Group Recent Development 
12.9 Compugen 
12.9.1 Compugen Company Details 
12.9.2 Company Description and Business Overview 
12.9.3 Immunoinformatics Introduction 
12.9.4 Compugen Revenue in Immunoinformatics Business (2014-2019) 
12.9.5 Compugen Recent Development 
12.10 Genedata AG 
12.10.1 Genedata AG Company Details 
12.10.2 Company Description and Business Overview 
12.10.3 Immunoinformatics Introduction 
12.10.4 Genedata AG Revenue in Immunoinformatics Business (2014-2019) 
12.10.5 Genedata AG Recent Development 
12.11 Insilico Biotechnology AG 
12.12 Leadscope Inc 
12.13 Nimbus Discovery 
12.14 Strand Life Sciences 
12.15 Schrodinger 
12.16 Simulation Plus 
12.17 Rosa & Co



Tags: , , , , , , , , , , , , , , , , , , , , , , , , , ,

See Campaign:
Contact Information:
Contact Us: Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

, Research Newswire, English